HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Comparison of safety and efficacy of foam-based versus solution-based ciprofloxacin for acute otitis externa.

AbstractOBJECTIVE:
To compare and evaluate the efficacy and safety of a foam-based antibiotic formulation in the treatment of acute otitis externa (AOE) with the more conventional solution-based formulation.
STUDY DESIGN:
Phase 2, open-label, randomized controlled trial.
SETTING:
Multicenter.
SUBJECTS AND METHODS:
Sixty-three eligible adult patients with unilateral AOE were randomly assigned to one of two treatment groups: an experimental 0.3 percent foam-based ciprofloxacin, (FoamOtic Cipro) or 0.3 percent solution-based ciprofloxacin (Ciloxan). All patients received the same dose regime (twice daily for 7 days). The primary efficacy variable was response to therapy (cure) in the test-of-cure visit. Secondary variables included improvement of the disease symptoms otalgia, tenderness, edema, and otorrhea.
RESULTS:
Sixty-four patients were enrolled in the study. Seven patients were excluded from the per-protocol analysis due to major deviations from the protocol. Per-protocol analysis (n = 57) showed that cure was achieved in all the patients (P = 1.000). No significant differences were found between groups for symptomatic relief, resolution of otic discharge, or onset of pain reduction. Both treatments were found to be highly efficacious and safe, demonstrating the noninferiority of the experimental drug.
CONCLUSION:
Foam-based ciprofloxacin is a safe and an effective new treatment for AOE.
AuthorsTal Marom, Rodrigo Yelin, Abraham Goldfarb, Yoseph Rakover, Lev Shlizerman, Eran Eilat, Yehudah Roth
JournalOtolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery (Otolaryngol Head Neck Surg) Vol. 143 Issue 4 Pg. 492-9 (Oct 2010) ISSN: 1097-6817 [Electronic] England
PMID20869557 (Publication Type: Clinical Trial, Phase II, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2010 American Academy of Otolaryngology–Head and Neck Surgery Foundation. Published by Mosby, Inc. All rights reserved.
Chemical References
  • Anti-Bacterial Agents
  • Dosage Forms
  • Solutions
  • Ciprofloxacin
Topics
  • Acute Disease
  • Adolescent
  • Adult
  • Aged
  • Anti-Bacterial Agents (administration & dosage, adverse effects)
  • Child
  • Ciprofloxacin (administration & dosage, adverse effects)
  • Dosage Forms
  • Female
  • Humans
  • Male
  • Middle Aged
  • Otitis Externa (drug therapy)
  • Pain Measurement
  • Solutions
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: